Literature DB >> 24257466

MicroRNAs and Lipoprotein Metabolism.

Takahiro Horie1, Osamu Baba, Yasuhide Kuwabara, Masayuki Yokode, Toru Kita, Takeshi Kimura, Koh Ono.   

Abstract

MicroRNAs(miRNAs; miRs) are small, non-protein-coding RNAs that negatively regulate the gene expression. They bind to specific mRNAs and inhibit translation or promote mRNA degradation. Recently, some miRNAs have been shown to be involved in lipid homoeostasis. In particular, miR122 and miR-33 have a significant impact on lipid homeostasis and are potential therapeutic targets for treating lipid disorders and/or atherosclerosis. In this review, we describe the current understanding of the function of miRNAs in lipid homeostasis, with a focus on lipoprotein metabolism.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24257466     DOI: 10.5551/jat.20859

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN: 1340-3478            Impact factor:   4.928


  14 in total

1.  Increased hepatic expression of miRNA-122 in patients infected with HCV genotype 3.

Authors:  Ketti G Oliveira; Fernanda M Malta; Ana C S S Nastri; Azzo Widman; Paola L Faria; Rúbia A F Santana; Venâncio A F Alves; Flair J Carrilho; João R R Pinho
Journal:  Med Microbiol Immunol       Date:  2015-08-14       Impact factor: 3.402

2.  Increased expression of miR-33a in monocytes from Mexican hypertensive patients in elevated carotid intima-media thickness.

Authors:  Yazmín Estela Torres-Paz; Claudia Huesca-Gómez; Fausto Sánchez-Muñoz; Rocío Martínez-Alvarado; Ma Elena Soto; Margarita Torres-Tamayo; Giovanny Fuentevilla-Álvarez; Ricardo Gamboa
Journal:  J Hum Hypertens       Date:  2018-09-19       Impact factor: 3.012

3.  Mutation of miR-21 targets endogenous lipoprotein receptor-related protein 6 and nonalcoholic fatty liver disease.

Authors:  Chang-Ping Li; Hong-Jue Li; Jiao Nie; Xia Chen; Xian Zhou
Journal:  Am J Transl Res       Date:  2017-02-15       Impact factor: 4.060

4.  MicroRNAs play an important role in contributing to arsenic susceptibility in the chronically exposed individuals of West Bengal, India.

Authors:  Nilanjana Banerjee; Subhadeep Das; Sucheta Tripathy; Apurba K Bandyopadhyay; Nilendu Sarma; Arun Bandyopadhyay; Ashok K Giri
Journal:  Environ Sci Pollut Res Int       Date:  2019-07-29       Impact factor: 4.223

Review 5.  The Role of MicroRNAs in Hyperlipidemia: From Pathogenesis to Therapeutical Application.

Authors:  Yu Xiang; Li Mao; Mei-Ling Zuo; Gui-Lin Song; Li-Ming Tan; Zhong-Bao Yang
Journal:  Mediators Inflamm       Date:  2022-06-17       Impact factor: 4.529

6.  Human MicroRNA-33b Promotes Atherosclerosis in Apoe-/- Mice.

Authors:  M Mahmood Hussain; Ira J Goldberg
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-10       Impact factor: 8.311

Review 7.  Hemostatic disorders of the menopausal period: the role of microRNA.

Authors:  Grzegorz Stachowiak; Agnieszka Zając; Marek Nowak; Tomasz Stetkiewicz; Jacek R Wilczyński
Journal:  Prz Menopauzalny       Date:  2015-06-22

8.  MicroRNA-33b knock-in mice for an intron of sterol regulatory element-binding factor 1 (Srebf1) exhibit reduced HDL-C in vivo.

Authors:  Takahiro Horie; Tomohiro Nishino; Osamu Baba; Yasuhide Kuwabara; Tetsushi Nakao; Masataka Nishiga; Shunsuke Usami; Masayasu Izuhara; Fumiko Nakazeki; Yuya Ide; Satoshi Koyama; Naoya Sowa; Naoya Yahagi; Hitoshi Shimano; Tomoyuki Nakamura; Koji Hasegawa; Noriaki Kume; Masayuki Yokode; Toru Kita; Takeshi Kimura; Koh Ono
Journal:  Sci Rep       Date:  2014-06-16       Impact factor: 4.379

Review 9.  Standing your ground to exoribonucleases: Function of Flavivirus long non-coding RNAs.

Authors:  Phillida A Charley; Jeffrey Wilusz
Journal:  Virus Res       Date:  2015-09-11       Impact factor: 3.303

Review 10.  Development of Antisense Drugs for Dyslipidemia.

Authors:  Tsuyoshi Yamamoto; Fumito Wada; Mariko Harada-Shiba
Journal:  J Atheroscler Thromb       Date:  2016-07-27       Impact factor: 4.928

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.